切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ribosomal s6 kinases (RSK) - RNA Polymerases - Insulin and Insulin-like Receptors - D4 Receptors

12件产品中的 1-10

页面
每页
清除全部
  1. BMH-21
    B4896 BMH-21
    Target: RNA Polymerases
    Summary: RNA聚合酶I抑制剂
      ≥7.4 mg/mL
      insoluble in H2O
  2. Pramipexole
    B1488 Pramipexole
    中文名: 普拉克索
    Target: D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 多巴胺激动剂
      ≥10.57 mg/mL
      insoluble in H2O
  3. Rifapentine
    B2127 Rifapentine
    中文名: 利福喷丁
    Target: RNA Polymerases
    Summary: 治疗肺结核的抗生素药物.
      ≥30.25 mg/mL
      insoluble in H2O
  4. T 705
    B1114 T 705
    中文名: 法匹拉韦
    Target: RNA Polymerases
    Summary: 有效的选择性RNA依赖性RNA聚合酶抑制剂
      ≥6.2 mg/mL
      ≥2.9 mg/mL
  5. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  6. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL
  7. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  8. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  9. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  10. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页